🔬Deep Research

TWST — Twist Bioscience Corp · catalysts, narrative & risks

·27 sourcesTWST forecast →

Snapshot (as of 2026-10-13)

Twist Bioscience (NASDAQ: TWST) is a South SF–headquartered synthetic biology company that manufactures custom DNA on a proprietary silicon-based platform [15], [24]. As of the research date, the stock trades around $152–153 [16], [17], implying a market capitalization of roughly $9.6B–10.6B, broadly consistent with the ~$10B figure on file [16], [17], [22], [24]. The stock has had an extraordinary run, up roughly +379% year-to-date and ~+387% over 12 months, with a 52-week range of roughly $23.30 to $205–220 (sources differ on the exact high) [17], [22], [24].


Recent Catalysts (last ~1–3 months)


AI-assisted research from the K3vl4r desk — not personalized investment advice. More research →